Literature DB >> 7033116

The effect of delayed addition of antigen and 'E' rosetting on the proliferative response to mycobacterial antigens of peripheral blood lymphocytes from normal individuals or from patients with tuberculosis or leprosy.

G M Bahr, G A Rook, J L Stanford, P M Lydyard, A D Bryceson.   

Abstract

Some suppressor cells are reported to lose their activity when precultured without stimulus in vitro. We have investigated the role of such suppressors in responsiveness to mycobacterial antigens of peripheral blood mononuclear cells (PBMNC) from patients with leprosy or tuberculosis, or from normal donors. Delayed addition of mycobacterial antigens (Mycobacterium leprae, Mycobacterium vaccae and Mycobacterium tuberculosis), but not of a fungal antigen (Candida albicans) caused enhanced responses using PBMNC from most normal donors, or tuberculoid leprosy (TT/BT) patients. However, the effect was less common using PBMNC from the lepromatous leprosy (BL/LL) group. (P less than 01.01, using M. leprae, relative to the TT/BT group), suggesting that this type of suppression reflects a normal mechanism, which is diminished rather than increased in anergic patients. Delayed addition of antigens to 'E'-rosetting cells did not result in enhanced responses. However, the different effects of 'E'-rosetting on the responses to the mycobacterial antigens of cells from normals, TT/BT and BL/LL patients, suggested that there may be two types of proliferative response to these antigens.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7033116      PMCID: PMC1554947     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

1.  Human leucocyte responses in vitro. I. Transformation of purified T lymphocytes with and without addition of partially purified monocytes.

Authors:  G S Hansen; B Rubin; S F Sorensen
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

2.  Immunosuppression in man: suppression by macrophages can be mediated by interactions with regulatory T cells.

Authors:  J D Stobo
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

3.  In vitro lymphocyte response to purified protein derivative, BCG and Mycobacterium leprae in a population not exposed to leprosy.

Authors:  O Closs
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

4.  Suppressor thymus-derived lymphocytes in fungal infection.

Authors:  J D Stobo; S Paul; R E Van Scoy; P E Hermans
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

5.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

6.  Role of B cells in the expression of the PPD response of human lymphocytes in vitro.

Authors:  H Blomgren
Journal:  Scand J Immunol       Date:  1975-09       Impact factor: 3.487

7.  Preliminary taxonomic studies on the leprosy bacillus.

Authors:  J L Stanford; G A Rook; J Convit; T Godal; G Kronvall; R J Rees; G P Walsh
Journal:  Br J Exp Pathol       Date:  1975-12

8.  Delineation of a human T cell subset responsible for lepromin-induced suppression in leprosy patients.

Authors:  V Mehra; L H Mason; W Rothman; E Reinherz; S F Schlossman; B R Bloom
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

9.  Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors.

Authors:  L Shou; S A Schwartz; R A Good
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

10.  Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG.

Authors:  L Moretta; S R Webb; C E Grossi; P M Lydyard; M D Cooper
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

View more
  3 in total

1.  Interleukin-1 released by blood-monocyte-derived macrophages from patients with leprosy.

Authors:  P R Ridel; P Jamet; Y Robin; M A Bach
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

2.  Antibody levels and in vitro lymphoproliferative responses to Streptococcus pyogenes erythrogenic toxin A and mitogen of patients with rheumatic fever.

Authors:  G M Bahr; A M Yousof; K Behbehani; H A Majeed; S Sakkalah; K Souan; I Jarrad; C Geoffroy; J E Alouf
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

3.  Evaluation of a monoclonal antibody (TB72) based serological test for tuberculosis.

Authors:  J Ivanyi; E Krambovitis; M Keen
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.